XORTX Therapeutics Inc
XORTX Therapeutics Inc, based in Calgary, AB, is a clinical pharmaceutical company focused on developing innovative therapies aimed at improving the quality of life for patients suffering from gout and progressive kidney diseases. The company is advancing several programs, including XRx026 for gout and XRx008 for Autosomal Dominant Polycystic Kidney Disease, which address issues related to aberrant purine metabolism and high uric acid levels.
With a commitment to redefining drug development through strategic collaborations, XORTX is also exploring treatments for conditions related to coronavirus infections and Type 2 Diabetic Nephropathy. Their pipeline reflects a dedication to creating first-in-class uric acid lowering agents to manage chronic kidney diseases effectively.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.